Strides Pharma Science announced that the Scheme of Demerger involving Arco Lab and Pivot Path became effective June 1, 2026, ...

Strides Pharma Science said the USFDA completed a routine cGMP inspection at its flagship Bengaluru facility from May 12 to May 20, 2026, and issued a Form 483 with five observations.

Strides Pharma - Read all the latest news headline updates on Strides Pharma. Get all the Strides Pharma breaking news updates, videos, photostories and more at Business Standard.

Strides Pharma Science Ltd (BOM:532531) reported a significant improvement in gross margins, reaching 60% in the quarter. The company achieved a 12% year-on-year increase in EBITDA, marking its ...

Get the latest news today on Strides Pharma Science Ltd. Follow Business Standard for the complete news coverage and key information about the Strides Pharma Science Ltd.

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2024-25. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes ...

BENGALURU (Reuters) - A U.S. Food and Drug Administration (FDA) investigator discovered that India's Strides Pharma Science Ltd, which exports to the U.S. market, was shredding drug production, ...

Founded in 1990, Strides Pharma Science is a global pharmaceutical company. The firm primarily invests in growth and early-stage ventures within the health tech and ...

The average one-year price target for Strides Pharma Science (NSEI:STAR) has been revised to ₹ 1,244.40 / share. This is a decrease of 19.21% from the prior estimate of ₹ 1,540.20 dated September 27, ...

The average one-year price target for Strides Pharma Science (NSE:STAR) has been revised to 565.76 / share. This is an increase of 13.66% from the prior estimate of 497.76 dated August 31, 2023. The ...

Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPF ...